The citrate transporter SLC13A5 as a therapeutic target for kidney disease: evidence from Mendelian randomization to inform drug development https://www.medrxiv.org/content/10.1101/2023.08.29.23294760
The citrate transporter SLC13A5 as a therapeutic target for kidney disease: evidence from Mendelian randomization to inform drug development https://www.medrxiv.org/content/10.1101/2023.08.29.23294760